** Shares of medical device maker AngioDynamics ANGO.O rise 31.6% to $12.37
** ANGO now expects 2025 adj. loss per share between $0.34 and $0.38, down from its prior projection of between $0.38 and $0.42
** Company continues to expect net sales in the range of $282 mln to $288 mln
** Posts Q2 net sales of $73 mln, up 9.2%
** Stock had risen ~17% in 2024
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.